期刊
CLINICAL IMMUNOLOGY
卷 119, 期 2, 页码 135-145出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2005.12.009
关键词
immunotherapy; retroviral transduction; T cell receptor; codon-modification; 2A peptide; HPV; gene therapy; adoptive transfer; codon optimization
类别
Expression of native transgenic T cell receptors in recipient human T cells is often insufficient to achieve highly reactive T cell bulks. Here we show that codon modification of an HPV16E7-specific T cell receptor (TCR), together with omission of mRNA instability motifs and (cryptic) splice sites, leads to a dramatic increase in the expression levels of the transgenic TCRs in human CD8+ T cells. The codon-modified TCRs have been tested in three different configurations in the retroviral vector LZRS: (1) TCR alpha-IRES-GFP in combination with TCR beta-IRES-NGFR, (2) TCR alpha-IRES-TCRI, and (3) TCR alpha-2A-TCR beta. T cells carrying the codon-modified TCRs are functionally active against target cells loaded with relevant peptide, model tumor cells expressing the specific epitope as well as cervical carcinoma cells. The significant improvements we report here in the functional expression of specific human TCRs wilt hopefully expedite clinical application of TCR transfer-based immunotherapy. (c) 2005 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据